secwatch.observer — SEC 8-K summary
======================================

Issuer:     PETMED EXPRESS INC (PETS)
CIK:        0001040130
Form:       8-K
Filed at:   2025-04-09T23:59:59+00:00
Accession:  0001040130-25-000016
Event type: leadership
Sentiment:  positive
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PetMed Express appoints Peter Batushansky to Board; Dr. Fulgoni to retire at 2025 annual meeting
--------------------------------------------------------------------------------

- Peter Batushansky, former CEO of Allivet and current partner at L2 Capital Partners, joins board effective April 9, 2025.
- Batushansky will serve on Audit Committee and Corporate Governance and Nominating Committee; board expands from 6 to 7 members.
- Dr. Gian Fulgoni, longtime board member and former Chairman, will retire when his term expires at the 2025 annual shareholders' meeting.
- This is the third independent director added since 2024; company highlights ongoing board refreshment and transformation strategy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1040130/000104013025000016/0001040130-25-000016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1040130/000104013025000016/pets-20250409.htm
  HTML page:      https://secwatch.observer/filing/0001040130-25-000016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer